GAMMA Investing’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.31K Buy
314
+24
+8% +$752 ﹤0.01% 3500
2026
Q2
$9.97K Sell
290
-40
-12% -$1.18K ﹤0.01% 3204
2026
Q1
$10.2K Buy
330
+301
+1,038% +$7.41K ﹤0.01% 3060
2025
Q4
$605 Buy
29
+21
+263% +$390 ﹤0.01% 3888
2025
Q3
$126 Buy
+8
New +$165 ﹤0.01% 3822
2025
Q2
– Sell
-8
Closed -$142 – 3906
2025
Q1
$142 Buy
+8
New +$261 ﹤0.01% 3773

Other funds holding TECX

GAMMA Investing's TECX Position: Q3 2026 in Review

GAMMA Investing increased its Tectonic Therapeutic (TECX) stake by 8.3% in Q3 2026, buying an estimated $752 and bringing the position to 314 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #3500.

GAMMA Investing first reported a position in TECX in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.2K in Q1 2026. 3 funds tracked by Wall St. Rank hold TECX as of Q3 2026.

  • GAMMA Investing held 314 shares of Tectonic Therapeutic worth $7.31K as of Q3 2026.
  • GAMMA Investing bought 24 Tectonic Therapeutic shares in Q3 2026, an estimated $752.
  • Tectonic Therapeutic made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3500 holding.
  • GAMMA Investing first reported a position in Tectonic Therapeutic in Q1 2025 and has held it in 6 quarters since.
  • GAMMA Investing's Tectonic Therapeutic position peaked at $10.2K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.